Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

The Market Online’s Weekly Cannabis Report – Nov. 8, 2024

Jonathon Brown Jonathon Brown, The Market Online
0 Comments| 3 hours ago

{{labelSign}}  Favorites
{{errorMessage}}

The Canadian healthcare sector offers a diverse range of investment opportunities, from companies developing cutting-edge drugs and therapies to those pioneering telehealth solutions. Several promising healthcare stocks that cater to various aspects of the healthcare market are listed on the TSX, including notable cannabis stocks.

Click to enlarge
(Stock image generated with A.I.)

Click here for the full story.

Weekly Update – Top Cannabis News Stories

1 | Cannabis processor and producer Adastra announces sale of Perceive MD to Majik Psilocybin Ventures Inc.

2 | Canada-based global medical cannabis company Aurora Cannabis releases its financial and operational results for its Q2 fiscal 2025.

3 | Curaleaf reports Q3 2024 results and secures new $40 million revolving credit facility

Click to enlarge

Top Cannabis Stocks Nov. 01 to Nov. 07, 2024

1. T.TLRY | 9,986 views | Tilray Brands Inc.
2. C.CURA | 3,521 views | Canopy Growth Corp.
3.T.WEED | 2,843 views | Curaleaf Holdings Inc.
4. T.LABS | 2,862 views | Medipharm Labs Corp.
5. C.OILS | 817 views | Nextleaf Solutions Ltd.
6. T.OGI | 774 views | OrganiGram Holdings Inc.


The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.




{{labelSign}}  Favorites
{{errorMessage}}